Background and Purpose-We assessed whether echocardiography can predict paroxysmal atrial fibrillation (PAF) in patients with cerebral ischemia presenting in sinus rhythm. 
A trial fibrillation is a frequent cause of ischemic stroke. 1 Diagnosing atrial fibrillation is relevant, as specific secondary prevention is highly effective, 2 but can be challenging when the arrhythmia is paroxysmal (PAF) and not present on admission. We have recently shown that prolonged Holter monitoring for up to 7 days triples the detection rate of PAF. 3 Toh et al have recently shown in a highly experimental setting that an index indicative of left atrial contractility can discriminate hypertensive patients with PAF from matched controls without the arrhythmia. 4 The aim of the current analysis was to evaluate this index in a contemporary cohort of patients with cerebral ischemia.
Methods
Details on the Find-AF trial (ISRCTN 46104198) have previously been published. 3 PAF was diagnosed by 7-day Holter monitoring 3 and PAF was defined as any atrial arrhythmia lasting Ͼ30 seconds.
Echocardiographic parameters were prospectively collected according to current guidelines. 5 The average of septal and lateral late diastolic peak tissue Doppler velocity, aЈ, was used in this study. Left ventricular mass was calculated by the Devereux formula 6 and indexed to body surface area. Left atrial volume was calculated by the ellipsoid formula 5 and indexed to body surface (LAVI). LAVI/aЈ was calculated as described by Toh et al. 4 Echocardiographers were blinded to results of 7-day Holter monitoring.
Differences between groups were tested as indicated. Multivariate analysis was performed by logistic regression correcting for age, sex, body mass index, systolic blood pressure, and history of heart failure. Receiver operating characteristics curves were constructed to assess discrimination between PAF and non-PAF.
Statistical tests were performed with PASW Statistics 18.0 software (SPSS, Inc).
Results
Of 281 consecutive patients included in Find-AF, 193 patients with sinus rhythm on admission and with echocardiography in sinus rhythm were included in this analysis. Of these, 26 patients had PAF, identified by medical history (nϭ2), 7-day Holter monitoring (nϭ23), or both (nϭ1; Table 1 Table 2 ). LAVI/aЈ Ͻ2.3, a cut-off previously reported, 4 had 92% sensitivity and 56% specificity with a resultant 98% negative predictive value for PAF in our cohort. Using this cut-off, 90 patients without PAF (55%) would have been excluded from additional 7-day Holter monitoring, with 2 of 25 PAFpatients (8%) being missed.
Discussion
The present analysis is the first to investigate echocardiographic indicators of left atrial function to detect PAF in patients with cerebral ischemia.
We find that parameters incorporating left atrial function differ between patients with or without PAF, discrimination by aЈ and LAVI/aЈ is reasonable, and the negative predictive value of LAVI/aЈ using the previously suggested cut-off Ͻ2.3 is confirmed to be very high.
Increased left atrial size and decreased atrial systolic function have previously been reported in subjects with PAF. 7 Areas under the curve for atrial echo parameters are lower than were previously reported, 4 but differences in study cohorts (stable hypertensive outpatients versus hospitalized stroke patients), unblinded 4 compared with blinded assessment in our study as well as matching controls for age and sex, may explain these differences.
We propose to use LAVI/aЈ to rule out the presence of PAF in patients presenting with cerebral ischemia to reduce the number of those undergoing prolonged electrocardiographic monitoring. In Find-AF, applying the cut-off of 2.3 would have reduced the number of patients to undergo 7-day Holter monitoring from 193 to 101 patients. With this approach, only 2 patients with PAF (8%) would have been missed. Interestingly, both patients had but 1 short episode of atrial fibrillation Ͻ1 minute.
Our analysis conceptionally represents a late step in evaluating a novel diagnostic marker by validating its usefulness in a real-life cohort.
Our analysis was performed post hoc, and echocardiography was not the focus of Find-AF (although parameters were prospectively collected), so additional validation is mandatory. More recent echocardiographic techniques, eg, strain rate, might further improve diagnostic accuracy.
Conclusions
LAVI/aЈ appears to effectively rule out PAF. We suggest to use this parameter routinely and to apply 7-day-Holtermonitoring selectively to those with LAVI/aЈ Ͼ2.3.
